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RACIAL DISPARITIES IN THE ALLOCATION OF
STEM CELLS
Andrea Flynn*
INTRODUCTION
On August 9, 2001, President Bush announced that the federal
government would fund research on the 64 stem cell lines that meet
certain criteria.' These stem cells must come from an embryo that was
created for reproductive purposes and was no longer needed for that
2purpose. A stem cell line is a colony of cells that grows from a single
embryo. 3  Federal funding is available for those stem cells that were
initiated prior to August 9, 2001 at 9:00 p.m. EST. The companies
should have obtained informed consent for the donation of the embryo
and the donation must not have involved financial inducements.4  The
Bush administration approved stem cell lines from fertility clinics
throughout the world.5
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' National Institutes of Health, Update on Existing Human Embryonic Stem Cells,
(August 27, 2001), at http://www.nih.gov/news/stemcell/082701ist.htm. [hereinafter NIH
Update].
2id.
3 Stem Cells: Scientific Progress and Future Research Directions, DEPARTMENT OF
HEALTH AND HUMAN SERVICES (June 2001), at http://www.nih.gov/news/stemcell/
scireport.htm, at ES-1.
4 id.
5Id. The University of G6tenborg has 19 stem cell lines that meet the eligibility criteria.
The nineteen lines are in various developmental stages but meet the eligibility criteria. The
Wisconsin Alumni Research Foundation owns five stem cell lines. They are licensed through
WiCell. Bresa Gen, Inc. in Athens, Georgia has four stem cells. CyThera, Inc. in San Diego,
California has nine lines, Karolinska Institute, Stockholm has five lines, Monash University,
Melbourne, Australia has six lines; the National Center for Biological Sciences, Bangalore,
India has three lines; Reliance Life Sciences, Mumbai, India has seven lines; Technion-lsrael
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Most of the embryos were harvested at clinics in the United States,
Australia, Sweden and Israel where the clinic populations consist
primarily of white couples while the other remaining lines were
harvested at clinics in Singapore and India. 6  The unintended
consequences could have a huge impact.7 Even if all of these stem cell
lines are shown to be viable for research, the lines cover a "very narrow
segment of the world's population and a tiny fraction of what is
necessary to ensure genetic diversity in therapies eventually developed
from these cells." 8 Medical geneticists have presented evidence
showing that certain diseases are specific to one population.9 If research
is limited to the current stem cell lines then certain drugs may be
developed that only work for certain populations. 
10
The health care system is not immune from the social injustices
and the various forms of inequality that impact other societal systems.
The United States health care industry has and continues to be plagued
by racism. During the pre-Civil war, Reconstruction and Jim Crow
eras of American history, overt racism was common in medicine. After
the Civil Rights Movement, segregation and some of the more blatant
manifestations of racism disappeared. However, subtle racism still
remains.
This Comment is divided into four sections. The first section
provides the reader with an overview of human stem cell research. It
provides brief background information of stem cells and their potential
uses. The second section examines race discrimination within the
American health care system. The third section proposes and analyzes
legal and non-legal responses to racial disparities in the allocation of
stem cells. The fourth section concludes that minorities should be
included in embryonic stem cell research.
Institute of Technology, Haifa, Israel has four lines, and the University of California, San
Francisco, CA has two lines.
6 Jon Entine and Sally Satel, Inserting Race into the Stem Cell Debate, THE WASH. POST,
Sept. 9, 2001, at B01.
7 id.
Sld.
9 National Medical Association, National Colloquium on African American Health, (July
23-25, 1999), at http://www.nmanet.org/Policy/05%20Biomed%20Rsrch.pdf, at 5.
10 Id.
[Vol. 6: 179
2002] RACIAL DISPARITIES IN THE ALLOCATION OF STEM CELLS 181
OVERVIEW
Background
In vitro fertilization (IVF) is a technique used to impregnate women.1'
IVF involves hormonal stimulation of a women's ovaries that suffer
12from defective fallopian tubes.' . Once the eggs are ripened they are
mixed with sperm. 13 The fertilized eggs are then put in vitro for a
period of time before they are implanted in the women's uterus.
14
Before the eggs are implanted, physicians must decide the number to
implant.' 5  If there are remaining embryos after implantation the
parents as the owners have the right to decide whether they are donated,
destroyed, or frozen cyrogenically for future use. 16
What are stem cells?
With the research of human stem cells, physicians hope these stem cells
will repair or replace damaged tissues that have been destroyed by
diseases and disabilities. 17 If physicians could control stem cells, they
could cure diseases such as Alzheimer's, Parkinson's Disease, or even
repair spinal cords.' 
8
Stem cells are the main cells that have the ability to turn into other
types of cells. 19 There are three different sources for stem cells:
embryonic stem cells, embryonic germ cells, and adult stem cells.20 .
Embryonic stem cells come from the inner cell mass of a blastocyst, a
very early embryo. 21 Embryonic stem cells are the cells that are in
embryos that have the ability to transform into almost any cell in the
'' DOROTHY ROBERTS, KILLING THE BLACK BODY347 (Pantheon Books 1997).
12 Id.
13 id.
14 id.
15 Id.
16 ROBERTS, supra note 11, at 247.
'7 Stem Cells: Scientific Progress and Future Research Directions, DEPARTMENT OF
HEALTH AND HUMAN SERVICES (June 2001), at http://www.nih.gov/news/stemcell/
scireport.htm, at ES-I.
18 Seattle Times news services, Here's What Debate on Stem Cells is All About, SEATTLE
TIMES, Aug. 10, 2001, at A2.
19 Id.
20 Audrey R. Chapman, Mark S. Frankel, and Michele S. Garfinkel , Stem Cell Research
and Applications Monitoring the Frontiers of Biomedical Research, AMERICAN ASSOCIATION
FOR THE ADVANCEMENT OF SCIENCE I (November 1999), at
http://www.aaas.org/spp/dspp/sfrl/projects/stem/report.pdf
21 Id.
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body. Master cells found in embryos generate all the other tissues in
the body.23
Pluripotent cells have the potential to reproduce into any type of
cell.24 An adult stem cell is found in a specialized tissue such as blood
and can reproduce itself for the lifetime of the organ. Scientists have
discovered that adult stem cells from one tissue seem to have the ability
to develop into stem cells that are characteristic of other tissue.
26
Sources of adult stem cells include bone marrow, blood, the cornea and
the retina of the eye, brain, skeletal muscle, dental pulp, liver, skin and
27pancreas. The fertilized egg is totipotent; it can generate all cells and
tissues that are in an embryo. 28 About four days after fertilization the
divided cells create a hollow sphere called an early blastocyst.
Human stem cells are pluripotent. The best source of embryonic
stem cell research comes from cyrogenically frozen human embryos
from IVF treatments. An embryonic stem cell is made from a group of
cells called the inner cell mass which is part of the early embryo called
the blastocyst. 29 Once the cell is separated from the blastocyst, the
cells of the inner cell mass can be cultured into embryonic stem cells.
30
These cells are not embryos. 3 1  Human embryonic cells can be
generated into large quantities in the laboratory and can grow in their
unspecialized state for a long period of time. 32 According to the
National Institute of Health (NIH), these cells do not react in the
laboratory than as they would in the developing embryo. 33 Embryonic
stem cells are more malleable than adult stem cells.34
There are many challenges and misconceptions to embryo stem
cells. 35 The lines of unchanged human embryonic stem cells will not
be able to be directly used in patients. 36 These lines of unchanged cells
22 See SEATFTLE TIMES, supra note 18.
23 id.
24 Stein Cells. Scientific Progress, supra note 17, at ES-1.
2 Id. at ES-2.
2 6 /d. at ES- 1.
27 Id. at ES-2.
21 Id. at 1.
29 Stem Cells: Scientific Progress, supra note 17, at ES-2.
30 m.
31id.
32 Id. at ES-9.
33 Id.
34 SteIn Cells: Scientific Progress, supra note 17, at ES-9.
3 Id. at ES-5.
36 id
[Vol. 6:179
2002] RACIAL DISPARITIES IN THE ALLOCATION OF STEM CELLS 183
will have to be modified in order to be used clinically. 37  Current
challenges include the ability to direct embryonic stem cells into
specialized stem cell populations and also to maintain control of their
development after inserted into patients.
39
Stem cells have the potential to cure many diseases by replacing
cells lost by crippling diseases. 39 One of the major foci of stem cell
research is the regeneration of replacement tissues for treating
neurological disease. 40 Researchers are currently studying what makes
certain cells become abnormal and why they make people get sick.
41
ANALYSIS AND IMPACT
The impact of limited stem cell research could be far reaching. For
example, Jacob Williams, a thirty-seven year old African American has
Parkinson's Disease. Jacob is constantly shaking, unable to walk, loses
his balance, and suffers from rigidity in his limbs.42 He is unable to
care for himself. He uses a wheelchair to move. Jacob decides to seek
help at the major research university near his hometown. Dr. Hope, the
premier researcher on embryo stem cell research, persuades Jacob to
seek treatment from the university's medical center for relief from his
Parkinson's disease. Dr. Hope assures Jacob that even though he is not
a candidate for a pallidotomy, he is an excellent candidate for embryo
stem cell research. Prior to the transplant, Dr. Hope explains to Jacob
and his family the success the university has had in its transplanting of
embryo stem cells for Parkinson's Disease. Dr. Hope reassures Jacob's
family that Jacob is an excellent candidate for the embryo stem cell
transplant. Jacob becomes excited about being independent and
teaching again. Dr. Hope offers him a new life with an embryo stem
cell transplant. Despite candid talks with his family, they are still
hesitant. Jacob's grandmother, the matriarch of the family, knows of
family members that were subjects in the Tuskegee Experiment and
strongly expresses her distrust of any medical study. Tammie, Jacob's
37 id.
38 id.
39 
m.
40 Stem Cells. Scientific Progress, supra note 17, at ES-4.
41 Id
42 Somerset Pharmaceuticals, What Happens in Parkinson's Disease, available at
http://www.parkinsonsinfo.com/about-parkinsons/whathappens.html (1997)
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wife, is optimistic and believes that medical science has changed and
everyone is treated equally. Other family members have various views.
Dr. Hope is confident about the new life Jacob would experience.
Dr. Hope explains that embryo stem cells are funded through research
by the federal government, and the tests were very safe and very
successful. However, Jacob's body rejects the embryo stem cells. His
conditions actually worsen. Disappointed, he and his family question
the doctor. Dr. Hope tells Jacob that this is the first time that he has
seen such a reaction.
Jacob's wife, Tammie, asks, "How many minorities were actually
tested?"
Dr. Hope stammers and tells them none.
"None!? How can the government fund a research program that is
supposed to benefit everyone and not test a diverse group of people?
That is not fair - nor is it legal."
Dr. Hope is embarrassed and disappointed because he cannot help
his patient. Dr. Hope led the research, but he had to admit that he had
not thought to include minorities in the study. He had to admit to the
Williams family that he did not think that minorities needed to be
included in the study.
Jacob's grandmother, Amelia, says, "That is why I don't trust
doctors.,
43
Mr. Williams is a fictitious character, but this scenario shows the
possible impact of excluding minorities from stem cell research.
Race Discrimination within the Health Care System
Courts have engaged in the past about health care groups and their
access to care. In the past, courts have allowed separation of health care
based on race. Courts currently view health care as a right, but there is
still unequal care.
African Americans' distrust of the health care system is built out of
a history that includes experimentation, the Sickle Cell Screening
Initiative, and the participation of the medical system in the
justification of racism and discrimination in society.44 The distrust of
43 LAURIE KAYE ABRAHAM, MAMA MIGHT BE BETTER OFF DEAD 203 (The University of
Chicago Press 1993).
44 ABRAHAM, at 203.
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the American health care system is grounded in the knowledge that the
health care system has been built on bodies of African Americans.45
Tuskegee Syphilis Experiment
In July 1932, the United States Public Health Services (PHS) enrolled
about 399 men infected with syphilis from Macon County, Alabama, in
a public health study. 46 The PHS selected men with late stage syphilis.
This showed that the purpose of the study was to determine the impact
of untreated syphilis during the final stage of the disease. 47 Most of the
men were unaware that they had contracted syphilis. 48 The physicians
working for PHS told them that they had "bad blood. 4 9  The
physicians knew that poor blacks in Macon attributed most ailments to
"bad blood.",50 The physicians did not tell them they could pass the
disease to their partners or their unborn children. 51 Most of the men
had never received regular health care services and were glad to have
regular access to physicians on a regular basis. The PHS used
incentives like free meals, physical exams, hot meals on exam dates
and burial stipends to encourage participation.
52
In the early years of the study, mercury and arsenic were used to
treat the patients. 53 In 1943, penicillin became an accepted form of
treatment for syphilis. In 1943, the Department of Public Health started
administering penicillin to syphilitic patients.54  However, these
participants in the Tuskegee study were denied treatment. 55 These men
were treated like laboratory animals. The men were not given
penicillin, because treatment would have ended the study. 56  For
example, men were also given pink-colored aspirin and iron tablets.
Physicians took advantage of the men's trusting nature and their
ignorance. The participants did not understand the purpose of the
experiment or the consequences of having syphilis untreated.
57
45 id.
46 JAMES H. JONES, BAD BLOOD I (The Free Press 1993).
47 id,
48 Id.
49 Id.
0 Id. at 73. JONES, supra note 46 at 73.
51 JONES, supra note 46 at 73.
52 Id. at 5.
53 JONES, supra note 46 at 118.54 Id. at 178.
55 id,
56[d at 179.
57 Id. at 13.
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Without the patients' consent, physicians conducted lumbar spinal taps
to test for the effect of syphilis on the central nervous system." The
physicians told the patients that they were giving them medicine. One
participating doctor justified the treatments by saying, "These Negroes
are very ignorant and easily influenced by things that would be of
minor significance in a more intelligent group."
59
Tuskegee participants who agreed to autopsies were given burial
stipends to insure that they would continue to participate in the study.
60
This eliminated their worry of burdening their family with expenses
after their death.
In July 1972, forty years after the experiment began, the men
discovered they had syphilis. In response, the Department of Health,
Education, and Welfare (HEW) revamped regulations on human
experimentation. 62 However, the damage was already done, and many
blacks were distrustful of medical authorities. 63 This study reinforced
the distrust African Americans had in the medical system. 64 Tuskegee
stood for the need to protect people from experiments that ignored
ethical issues.
65
Sickle Cell Anemia Screening
Sickle cell anemia is an inherited blood disorder, characterized by
chronic anemia and periodic episodes of pain. 66  Sickle cell anemia
affects African Americans and people of Mediterranean descent. 67 It is
caused by an error in the gene that tells the body how to make
hemoglobin. 68 This defective gene tells the body to make the abnormal
hemoglobin that results in deformed red blood cells. 69 Children who
inherit copies of the defective gene from both parents will have sickle
58 d. at 123.
59 JONES, supra note 46, at 123.
601d. at 153.
61 Id. at 1.
12I. at 214.
631d. at 223.
64 Vernellia L. Randall, Slavery, Segregation and Racism: Trusting the Health Care
System Ain't Always Easy! An African Perspective on Bioethics, 15 ST. Louis, U. PUB. L. REV.
191, 198 (1996).
65 JONES, supra note 46, at 14.
66 What is Sickle Cell Anemia?, American Sickle Cell Anemia Association, at
http://www.ascaa.org/ whatis.htm. [hereinafter What is?].67 What Causes Sickle Cell Anemia?, American Sickle Cell Anemia Association, at
http://www.ascaa.org/ cause.htm. [hereinafter What Causes?].
68 id.
69 ld.
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cell anemia.70 Children who inherit the defective sickle cell gene from
one parent will have the sickle cell trait.7 1 People with the sickle cell
trait generally have no symptoms, but can pass the sickle cell gene to
their children. 72 The trait does provide resistance to malaria, a benefit
to people in parts of Africa where the gene is most prevalent.73
More than forty states perform a blood test on all newborn
infants.74 These tests are performed at the same time and from the
same samples as other routine newborn screening tests.75 Hemoglobin
electrophoresis is the most popular diagnostic test.
76
In 1972, Congress passed the National Sickle Cell Anemia Control
Act.7 7 The Sickle Cell Anemia Act provided for research, screening,
counseling and education. 78 By 1975, more than 250 screening
programs nationwide tested about half a million Blacks for sickle cell
anemia. Initially, Congress passed the Act to improve the health of
Blacks; however, it soon became a tool for racial discrimination.
Fourteen states made testing mandatory for Blacks entering school,
obtaining a marriage license or confined in prison.79
The excitement over the sickle cell trait led to discrimination
against Blacks. The autopsies of four Black army recruits showed
severe sickling of their red blood cells.8 1 The fact that a sickle carrier's
blood cells could possibly sickle at high altitudes was used to justify
Blacks' exclusion into the Air Force Academy.82 Many major airlines
fired flight attendants and pilots with the sickle cell trait.83 Sickle cell
carriers were also either charged higher insurance premiums by
companies or denied insurance. 84
70 Id.
71 id.
72 See What Causes?, supra note 66.
73 Id.
74 How is Sickle Cell Anemia Detected?, American Sickle Cell Anemia Association, at
http://www.ascaa.org/detect.htm.
75 How is Sickle Cell Anemia Detected?, supra note 73.
76 Id.
77 DOROTHY ROBERTS, KILLING THE BLACK BODY 257 (1997).
78 Id.
79 ld.
80 Id.
81 Id.
82 ROBERTS, supra note 76, at 257.
83 Id. at 258.
84 id.
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In vitro fertilization
People are using in vitro fertilization (IVF) to conceive. 85 Even though
Blacks have a higher infertility rate than whites, they are not receiving
the benefits IVF provides." Blacks have a higher fertility rate due to
untreated sexually transmitted diseases and other barriers to health
care. 87 Furthermore, the high cost of IVF treatments is too expensive
for most Black families. 88 The average cost of TVF treatments is
$8,000. 89 Most insurance plans including Medicaid will not reimburse
IVF services. 90 Without some type of additional subsidy, only a small
minority of Blacks can afford IVF. 91
Since few Blacks can afford IVF treatments, they are virtually
excluded from stem cell research. Blacks do not have the opportunity
to decide if there are remaining embryos after implantation, or to
decide whether to donate, destroy or freeze cyrogenically their eggs for
future use.
LEGAL RESPONSES TO RACIAL DISPARITIES IN STEM
CELL RESEARCH
Potential Claims Under the Equal Protection Clause of the
Fourteenth Amendment to the United States Constitution
There is the possibility that a plaintiff could bring a claim under the
Equal Protection Clause of the Fourteenth Amendment. 92 There is a
possibility of pursuing greater racial equality in stem cell research;
however, obstacles stand in the way of potential Equal Protection
claims. For an effective Equal Protection Claim, the plaintiff must
prove state action and an intention to discriminate.
93
The Supreme Court determines whether the defendant is engaged
in a public function, or whether a connection exists between the
8 Id. at 246.
16 ld. at 252.
87 ROBERTS, supra note 76, at 252.
88 d. at 253.
89 Id.
90 Id.
91 Id.
92 U.S. CONST. amend. XIV §1.
93 See, e.g., Personnel Administrator v. Feeney, 442 U. S. 256 (1979) (discriminatory
impact is not enough to prove gender classification; plaintiff must prove a discriminatory
purpose); Washington v. Davis, 426 U.S. 229 (1976) discussed below.
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defendant and the government or whether the government compels the
harm caused by defendant.
To win under the Fourteenth amendment, a plaintiff would have to
show that the government intended to discriminate against minorities.
For example in Washington v. Davis, the Supreme Court stated that
there must be intentional, purposeful, discrimination to state a claim
under the Equal Protection Clause.94  Discriminatory impact is not
enough to establish a prima facie case of a Fourteenth Amendment
Equal Protection claim. 95 Plaintiffs may find it difficult to prove that
the government used purposeful discrimination. However, a potential
plaintiff could argue that even though the stem cells guidelines
are not facially discriminatory, the stem cell lines are the equivalent of
a racial classification and the Supreme Court is required to evaluate the
stem cell lines under strict scrutiny. However, a potential plaintiff
would have to prove the significant obstacles of state action and intent
to discriminate. An equal protection claim may not be the best legal
option for a minority plaintiff.
Title VI of the Civil Rights Act of 1964
Before the passage of Title VI of the Civil Rights Act, racial
discrimination was pervasive. Hospitals and health care facilities
openly discriminated. 96  In 1964, Congress enacted Title VI to end
discrimination against racial and ethnic minorities. 97 Title VI requires
programs receiving federal funds to treat individuals of different races,
colors and national origins equally. 98 Title VI curtailed blatant racism
in health care facilities. 99 However, subtle racism still prevents African
Americans from receiving complete access to federally funded
programs and medical facilities. Title VI gives the government the
authority to determine how programs are funded. lOO
Anyone receiving federal funding must accept the conditions
attached to the receipt of those funds, or they can forego federal
94 Washington, 426 U.S. at 239.
95 Id.
96 Amy Jurevic, Disparate Impact Under Title VI: Discrimination, by Any Other Name,
Will Still Have The Same Impact, 15 ST. Louis U. PuB. L. RFV. 237, 238 (1996).
97 H.R. REP. No. 914, at 2355 (1964).
9' 42 U.S.C. § 2000d (2002).
99 Id. Title VI states: "No person in the United States shall, on the ground of race, color
or national origin be excluded from participation in, be denied the benefits of, or be subjected
to discrimination under any program or activity receiving Federal financial assistance."
100 Id.
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funding and be free of the legal obligation to treat races equally. 10 1 The
spending of Title VI comes from the spending power of the
Constitution and depends on administrative procedures for
enforcement. Title VI's enforcement mechanism is administrative.
Yet disparate impact is a constant problem in the health care
setting. Disparate impact includes those practices that adversely affect
one group more than another regardless of intent. 102 The Supreme
Court introduced the theory of disparate impact discrimination in
Griggs v. Duke Power Co.'0 3 The Court held that a plaintiff need not
necessarily prove intentional discrimination to establish an employer's
violation of Title VII of the Civil Rights Act. 104 Although the disparate
impact theory was originally created for employment discrimination,
courts now apply the theory to claims brought pursuant to Title VI
cases. 105
To prove a Title VI disparate impact, a plaintiff must demonstrate
that a facially neutral selection practice has caused a racially
disproportionate impact. 106  Second, upon a successful showing by
plaintiff, the burden of rebuttal shifts to the defendant, who must show
that the selection practice causing the disproportionate effect is justified
by an educational "necessity."' 1 7 On rebuttal, the defendant only bears
a burden of producing evidence to support its educational necessity.
108
Finally, should the defendant meet its burden of production, plaintiff
may nonetheless prevail by: (1) discrediting the asserted educational
necessity or (2) proffering an equally effective alternative practice
resulting in less disparate impact while still advancing the articulated
educational necessity.
The Court reviewed the reach of Title VI in Guardians
Association v. Civil Service Commission.109 In Guardians, Black and
Hispanic police officers filed a class action challenging the use of
written examinations to hire entry level officers to the New York City
Police Department.)10 Minorities scored lower on the tests.'" Since
101 1d.
102 Griggs v. Duke Power Co., 401 U.S. 424 (1971).
103 id.
104 id.
1o5 See Guardians Ass'n. v. Civil Service Commission, 463 U.S. 582 (1983)
'o6 I. at 593.
0o7 Id. at 598.
108 Id.
109 Guardians, 463 U.S. at 582.
" o Id. at 585.
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appointments were based on test scores, minorities were hired after
Whites.112 The New York Police Department laid off police officers on
a "last-hired, first-fired" basis. The officers with the lowest test scores
were laid off first, causing proportionately more Black and Hispanic
officers to be fired.1 3 The plaintiffs brought a class action alleging that
the examinations violated Title VI and Title VII, because they had a
disproportionate impact on minority applicants. 114 The district court
held that an implied private right of action existed under Title VI and
that proof of discriminatory effect was enough to establish a violation
of Title VI.' It rejected the Police Department's argument that only
proof of discriminatory intent was sufficient. The district court found
that the same equitable relief available under Title VII should be
provided under Title VI. 116 The court awarded constructive seniority,
backpay, and back medical and insurance benefits.1 17 The Second
Circuit affirmed the Title VII relief but reversed as to Title VI. 11"
Guardians resolved that private Title VI plaintiffs can prevail
upon a showing of disproportionate adverse impact without proof of
intent to discriminate as long as they are careful to allege a violation of
the Title VI regulations. 119 The case left open, though, the question of
the relief available to Title VI plaintiffs. 2 °
Yet a different Guardians majority than those that coalesced
around the intent versus impact issues concluded that both prospective
and retrospective equitable relief were available to Title VI plaintiffs
who proved either intentional or unintentional discrimination. Justices
Stevens, Brennan, Blackmun, and Marshall reasoned that both
prospective and retrospective legal and equitable relief were available
to all Title VI plaintiffs. Justice O'Connor, concurred that proof of
intent was a required element, agreed that both prospective and
retrospective equitable relief were available to all Title VI plaintiffs,
11 d.
12 Id.
'
3 Id. at 585.
114 Guardians Ass'n, 463 U.S at 586.
115 Id. at 587.
116 id.
11
7 Id. at 588.
118 Id.
19 Guardians Ass'n, 463 U.S. at 602.
120 Id. at 607.
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but reserved judgment on the question of whether there is a private
cause of action for damages relief under Title VI. 2 '
Since Guardians, the Court has not addressed directly the question
of whether plaintiffs who prove disproportionate adverse impact
discrimination may recover retroactive, equitable relief. However, a
unanimous Court has cited Guardians saying that "[a] majority of the
Court agreed that retroactive relief is available to private plaintiffs for
all discrimination, whether intentional or unintentional, that is
actionable under Title VJ."' 22 The Court has not characterized this
majority vote as a "holding," although it has so characterized its
majority votes on disproportionate adverse impact theory. Thus, the
precedential effect of the remedies vote, given the change in Supreme
Court personnel since Guardians, is unknown. The remedies question
is generally of marginal importance only in Title VI health care cases
because such actions typically seek prospective injunctive relief rather
than any form of retrospective relief. In its tortured way Guardians
resolved that Title VI plaintiffs could prevail upon a showing of
disproportionate adverse impact.123 Yet because the Supreme Court
affirmed the Second Circuit's reversal of the trial court's judgment,
Guardians did not reach the issue of the parties' evidentiary burdens in
a Title VI disproportionate adverse impact discrimination suit. These
are important issues. The nature of the defenses available in a Title VI
disproportionate adverse impact case -- which party has the burden of
producing evidence and who bears the risk of non-persuasion -- can be
determinative of the outcome in any Title VI case. These Title VI
questions remain unsettled. In Alexander v. Choate the Court referred
to a majority in Guardians as "holding" that Title VI itself, apart from
its regulations, reaches only intentional discrimination.' 24  The
Alexander court also referred to Guardians as "holding" that the Title
VI implementing regulations that prohibit facially neutral policies
having an unjustified disparate impact were valid. 125
Title VI litigation has not ended health care discrimination caused
by these facially neutral policies with a disproportionate impact on
minorities. Title VI's implementing regulations proscribe facially
neutral policies and practices that, in operation, have the effect of
121 Id. at 612.
122 Consolidated Rail Corp v. Darrone, 465 U.S. 624, 631 n.9 (1984).
123 See Guardians, 463 U.S. 582.
124 Alexander v. Choate, 105 S. Ct. 712, 716 (1985).
2 Id. at 716.
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disproportionately excluding minorities, regardless of the defendant's
lack of subjective discriminatory intent. But lower courts have allowed
hospitals to defend too easily such policies. In the health care setting,
federally funded defendants have been allowed to successfully defend
policies with a disproportionate adverse racial impact by showing that
the policies are rationally related to any legitimate, non-discriminatory
purpose. 126 Thus, Title VI's authors drafted an administrative
compliance mechanism empowering the federal agencies that award
federal financial assistance to refuse to grant funds and to terminate
funding to any recipient found in violation of the Title VI regulations
after an opportunity for an administrative hearing. 127  The federal
agency does not need to seek a court order, but the funding recipient
may seek judicial review of agency action.
Although a federal funding recipient may not discriminate in any
of its activities if any part receives federal financial assistance, the
administrative sanction for violation of Title VI is termination of
federal funds only to the "particular program, or part thereof, in which
such noncompliance has been so found."1 28 Federal funds specified for
a specific purpose are not terminated unless discrimination is found in
the use of those funds or the use of those funds is infected by
discrimination elsewhere in the operation of the recipient.
Title VI provides expressly only for administrative enforcement.
However, the Supreme Court has implied a cause of action for private
individuals to sue to enforce both the statute and its implementing
regulations. 129 The remedies available to a private plaintiff in a court
action do not include termination of federal funding, but a plaintiff who
proves intentional discrimination can recover both equitable
retrospective and prospective relief, including backpay. The Court has
not yet addressed whether such a plaintiff can also recover damages.
The Court has also left open the question of the relief available to a
Title VI plaintiff who proves disproportionate adverse impact
discrimination but who does not prove intent to discriminate. While
the Eleventh Amendment prohibits Title VI suits in federal court
against a state for compensatory monetary damages, this prohibition
126 See, e.g., Bryan v. Koch, 627 F.2d 612, 668 (2d Cir. 1980); NAACP v. Med Ctr. Inc.,
657 F.2d 1322, 1332 (3d Cir. 1981).
127 See 42 U.S.C.A. § 2000d, Official Comments (2002).
128 42 U.S.C.A. § 2000d (2002).
129 Guardians Ass'n, 463 U.S. at 582.
DEPAUL JOURNAL OF HEALTH CARE LAW
does not extend to suits against state officials for prospective injunctive
relief.
Title VI does not specifically explain discrimination. Rather, it
directs each federal administrative agency that provides federal
financial assistance to enforce "rules, regulations, or orders of general
applicability" effectuating the provisions of Title VI. 3 The Title VI
regulations all define prohibited "discrimination" in the same general
terms prohibiting, among other things, "criteria or methods of
administration which have the effect of subjecting individuals to
discrimination because of their race, color, or national origin, or have
the effect of defeating or substantially impairing accomplishment of the
objectives of the program as respect individuals of a particular race,
color, or national origin."' 131 While the administrative agencies charged
with enforcing Title VI have been unanimous and consistent in
concluding that Title VI should prohibit policies and practices that have
a disproportionate adverse impact on minorities, the Supreme Court has
not been consistent with its rulings.
The Title VI health care cases involve situations that are
significantly different from the facts normally analyzed under Title VII.
At the appellate level, Bryan v. Koch132 concerns a decision to close a
public hospital, while NAACP v. Medical Center, Inc.' 33 involves a
decision to relocate a non-profit hospital. Rather than applying Title
VII standards, Bryan holds and NAACP implies that in the Title VI
health care context, a policy with a disparate impact can be justified by
showing merely that the policy is rationally related to a legitimate need.
Bryan arose when the city of New York decided to close
Sydenham Hospital, a public hospital that served a large minority
population. 134 Plaintiffs filed a Title VI action alleging that the closing
of Sydenham had a disparate impact on Blacks and Hispanics.' 35 The
court unanimously held that the plaintiffs had established a prima facie
30 42 U.S.C.A. § 2000d-1 (2002) reads: Each federal department and agency which is
empowered to extend Federal financial assistance to any program or activity, by way of grant,
loan, or contract ... is authorized and directed to effectuate the provisions of section 2000d of
this title with respect to such program or activity by issuing rules, regulations, or orders of
general applicability which shall be consistent with achievement of the objectives of the statute
authorizing the financial assistance in connection with which the action is taken.
131 45 C.F.R. § 80.3(b)(l)(vii)(2) (2002).
132 Bryan v. Koch, 627 F.2d 612, (2d Cir. 1980).
13' NAACP v. Med. Ctr. Inc., 657 F.2d 1322, (3d Cir. 1981).
114 Bryan, 627 F.2d at 614.
13 M. at 614.
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case of disparate impact. 136 The court inquired instead whether the
decision to close Sydenham was rationally related to a legitimate
objective. 137 New York City's reasoning for closing Sydenham was
that the closure would reduce total hospital expenditures and would
increase efficiency within the municipal hospital system. 138 The court
found that the city's goal of saving money and increasing efficiency
was obviously a legitimate objective. 139  The court then reviewed
whether the criteria used to decide which hospital to close were
reasonably related to reducing expenditures and increasing efficiency
and whether the decision to close Sydenham was justified according to
these criteria. 140 Since the plaintiffs did not disagree that Sydenham
was the appropriate hospital to close if New York had to close, the
court found that the city's decision to close Sydenham withstood this
rational relationship scrutiny. 141 Plaintiffs argued that the city could
save just as much money and increase hospital efficiency with less
impact on minorities by regionalizing hospital services, merging
hospitals or increasing Sydenham's services to make it more profitable
to operate rather than closing Sydenham or any public hospital. 142 The
court feared that an alternative inquiry that went beyond the question of
which hospital to close would impinge upon elected officials' discretion
to run their city government.
The second Title VI health care decision to address the defendant's
burden of justification arose in the context of a hospital site
controversy. NAACP involved a proposed hospital reorganization and
relocation from the predominately Black inner city of Wilmington,
Delaware, to a predominately white suburb. 143 First plaintiffs alleged
that the relocation plan violated Title VI because the Medical Center's
remaining urban facility would become a "ghetto hospital" serving
primarily minorities, the poor, elderly and handicapped, while the
proposed suburban hospital would treat only the more affluent, white
population. 144  Second, the plaintiffs alleged that the relocation of
certain acute care services exclusively to the new suburban hospital
136 id.
13 Id. at 620.
131 Id. at 618.
139 Bryan, 627 F.2d at 620.
14 0 Id. at 617.
141 Id. at 620.
142 id.
143 NAACP, 657 F.2d 1322.
144 Id. at 1324.
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would make them virtually inaccessible to many handicapped and
minority residents. 145
The Third Circuit, sitting en banc, assumed that the plaintiffs had
established a prima facie case of disparate impact but affirmed the
district court's finding that the defendant had met its burden of
justification.14 6 The court held that the Title VI plaintiff bore the risk
of non-persuasion on the defendant's justification in a Title VI case. 147
The court affirmed the district court's analysis that the defendant
had met its burden of justification. The district court had required that
the relocation serve a legitimate bona fide interest and that there be no
less discriminatory alternative. In affirming, a plurality characterized
the district court's standard as more stringent than a rational
relationship test and "more than adequately served Title VI aims,"
while suggesting that the appropriate standard for judging a Title VI
defendant's justification was a rational relationship test required by the
Constitution. 148
The rational relationship test articulated in Bryan and NAACP is
so undemanding that a decision to use the standard is tantamount to
holding that the challenged policy is valid. Rational relationship
scrutiny merely inquires whether there is any relationship between the
challenged practice and any legitimate goal. It strikes down only
classifications that are arbitrary because they fail to advance any
legitimate goal. Rational relationship scrutiny does not require any
degree of correlation; it asks merely if there is any relationship.
Any disproportionate adverse impact should require a heavier
burden of justification than mere rational relationship. For example in
Washington v. Davis, the Supreme Court held that the Constitution did
not prohibit policies and practices with a disproportionate adverse
racial impact, but required merely that such policies, like all
governmental classifications, be justified as at least bearing a rational
relationship to some legitimate governmental goal. 149 The Title VI
regulations forbidding facially neutral policies that impact
disproportionately on minorities reach beyond this constitutional
prohibition to forbid facially neutral policies that can be justified under
a rational relationship test. By definition, a prohibition on
45 Id. at 1326.
146 Id. at 1336.
147 id.
148 See id. at 1337 n. 18.
149 Washington, 426 U.S. at 239.
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disproportionate adverse impact discrimination requires a more
stringent justification than the mere rational relationship required by the
Constitution.
Title VI allows private parties to file legal complaints alleging a
Title VI violation. 150 In response to racial discrimination in the health
care sector, plaintiffs have used Title VI in attempts to prevent
hospitals geographically placed in predominantly black communities
from closing or relocating to white neighborhoods. 151 The Supreme
Court has recognized that Title VI applies when there is
disproportionate adverse impact discrimination, without proof of intent
to discriminate as long as the plaintiff alleges a violation of Title VI's
implementing regulations. In Alexander v. Choate, the Court held that
Title VI applies only to intentional discrimination. 152 In Alexander,
Medicaid recipients brought a class action for declaratory judgment and
injunctive relief against the state of Tennessee Medicaid's reduction of
inpatient hospital days. 153  Second, respondents argued that any
limitation was likely to disadvantage the handicapped
disproportionately. 54 Respondents argued that the change from 20 to
14 days of Medicaid coverage would have a disproportionate effect on
the handicapped and was discriminatory.' 55 The court added that Title
VI plaintiffs could state a claim by showing a disproportionate adverse
impact without proof of intent to discriminate as long as the plaintiff
alleged a violation of Title VI implementing regulations.
A federally funded health care defendant should do more than
merely assert that the policy furthers an important purpose. It should
introduce some empirical evidence establishing that the challenged
practice is, in fact, effective in furthering an important program need.
The higher the disproportionate adverse impact the more effective the
challenged practice needs to be to justify its continued use. For
example, if a policy excluded almost all minority patients while only
incrementally improving the quality of patient care, the policy would
not "significantly" further the important, legitimate objective of non-
discriminatory, high-quality care. In effect, the requirement of a
"significant" relationship creates a balancing test. However, the
150 42 U.S.C. § 2000d (2002).
151 Alexander v. Choate, 469 U.S.287, 293. (1985).
152 id.
' Id. at 289.
154 Id. at 290.
"' Id. at 715.
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purpose of the proposed Title VI standard is to create
nondiscriminatory alternatives. Rather than inquiring directly into the
strength of the relationship between the policy chosen and the goal
sought, evidence of less discriminatory alternatives provides a
framework for evaluating a health care provider's need for a facially
neutral practice that disparately impacts minorities. In Alexander, the
existence of workable alternatives proves that the challenged policy is
insufficiently related to the hospital's asserted goal or that the hospital's
interests advanced by a particular policy are not important enough to
justify use of the policy in light of its disparate racial impact.' 56
Nevertheless, minorities still do not get the health care services
they need nor are they fully integrated into the mainstream of American
health care. Longstanding hospital policies, such as private physician
rules and pre-admission deposits, still operate to exclude minority
patients from federally funded health care.
Courts should not be reluctant to scrutinize the operation of
federally funded programs. Title VI is a spending power statute. 157 It
does not regulate, but places conditions on the expenditure of federal
money.1 58 As a condition of receipt of federal Medicaid and Medicare
money, hospitals and other health care providers guarantee that they
will not use policies and practices that have the effect of excluding
minority patients. Courts should hold health care providers to their
promise. 159
It is highly likely that under embryonic stem cell research, a
minority plaintiff could bring a case against Health and Human
Services. First, the federal financial assistance requirement is met. The
companies that are participating are receiving federal funding. Second,
the plaintiff would have to show that Title VI implementing regulations
that forbid organizations receiving federal funding from using "criteria
or methods of administration which have the effect of subjecting
individuals to discrimination because of their race, colors or national
origin, or have the effect of defeating or substantially impairing the
accomplishments of the objects of the program as respect individuals of
a particular race, color, or national origin.
Stem cell research policies are "facially neutral policies that have a
disproportionate adverse impact." They are "facially neutral" because
156 Alexander, 105 S. Ct. at 715.
117 See Guardians Ass'n, 463 U.S. at 599.
158 ld.
159 ld.
[Vol. 6:179
2002] RACIAL DISPARITIES IN THE ALLOCATION OF STEM CELLS 199
they may not have been enacted with the subjective intent of
discriminating. Their impact is disproportionate because they hit the
poor and minorities harder than other groups. Their effect is adverse
because in the health care context such exclusionary policies can be
deadly.
Stem cell research is supposed to be for the community. The
government has an obligation to preserve and save lives. The federal
government's role is to ensure that basic research occurs.' 60 The state
has an obligation to protect and keep the community safe. 16 1 Stem cell
research is an example of a policy of mixed moral considerations and
obligations. The state has an obligation to preserve the lives and the
health of its members. However, not every member of the country is
equally represented in the stem cell research project. The National
Institute of Health (NIH) justifies its current number of stem cells. NIH
argues that it is currently too early to determine benefits, and it will
only know with considerable future research. 162 However, if minorities
are not included in the basic research, how can they be certain they will
benefit from cures once they are discovered? Secretary Thompson
argued that research has been conducted on mice using only five stem
cell lines.
CONCLUSION
The federal government has made a significant financial commitment
to healthcare. Health care spending is one of the largest components of
the federal budget, accounting for 193 billion federal dollars in 2002.163
Federal money, primarily Medicaid and Medicare, pays for
approximately 30% of the total costs of health care in the United
States. 164 The federal government's role is greatest in the health care
sector, where federal dollars pay for 43% of the care provided, but
160 Tommy G. Thompson, Speech to Senate Health, Education Labor and Pensions
Committee: Embryonic Stem Cell Research (Sept. 5, 2001, available at
http://www.hhs.gov.news/speech/2001/010905.html.
161 Michelle Goodwin, Deconstructing Legislative Consent Law: Organ Taking, Racial
Profiling and Distributive Justice, 6 VA. J. L. & TECH. 2 (Spring 2001).
162 NIH Update, supra note 1.
163 Budget of the United States Government 97 (2002).
164 Hispanic and Black Americans Still More Likely than Whites to be Uninsured,
AGENCY FOR HEALTH CARE RESEARCH AND QUALITY PRESS RELEASE, available at,
http:www.ahrq.gov/news/press/pr2000/meps98r.htm (Aug. 2, 2000)
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federal money also pays for 24% of doctors' fees and 27% of nursing
home costs.1
65
However, minority Americans are still in worse health and receive
less health care than white Americans. Although Blacks are generally
in worse health than Whites, they receive fewer services from doctors
and hospitals. Blacks have a lower percentage of usual sources of
medical care than Whites.166 A disproportionate number of Blacks rely
on hospital emergency rooms and outpatient clinics for primary care.
167
If minorities are ever to gain full access to America's health care
system, judges must stringently scrutinize facially neutral policies that
exclude a disproportionate number of minority patients. Title VI's
implementing regulations specifically prohibit facially neutral policies
that have the effect of discriminating against minorities, and courts
should strictly construe the regulations. Companies testing embryo
stem cells bear a heavy burden to justify such policies and to show that
there are no less discriminatory alternatives available. Business as
usual is not delivering health care to minority Americans.
165 id.
166 J.L. Hargraves, P.. Cunningham, and R.G. Hughes, Racial Disparities in Access to
Care Pervasive in Managed Care Plans, ROBERT WOOD JOHNSON FOUNDATION, available at
http://www.rwjforg/publications/advances/2002_issue_I /abridgeljhtml (2002).
Rwj f.org/publications/advances/2002_Issue I/abridge I .jhtml.
167 id.
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